priceTarget News & Analysis
5 articles
Market Mood
Netflix (NFLX) Rated Outperform with $115 Target, Margin Growth Projections
On March 12, Bernstein SocGen Group reaffirmed an Outperform rating for Netflix, Inc. (NASDAQ: NFLX) with a price target of $115. The company reported a margin growth of 600 basis points in 2024 and 400 basis points in 2025, excluding Brazil's impact. For 2026, Netflix projects a 31.5% margin, up 50 basis points from 2025. Argus, however, lowered its price target from $141 to $110 while maintaining a Buy rating. This analysis reflects ongoing changes in Netflix's strategy and market position.
Read More
Apple Inc. Maintains Sector Weight Rating Amid 9% Spending Decline
On March 12, 2026, KeyBanc reaffirmed a Sector Weight rating for Apple Inc. (NASDAQ: AAPL), noting a 9% month-over-month decrease in indexed spending, compared to a three-year average drop of 4%. The firm indicated that this data aligns with forecasts, and its projections for fiscal year 2026 are consistent with expectations and slightly below consensus for fiscal year 2027. Additionally, on March 5, Rosenblatt raised its price target for Apple to $268, reflecting optimism on recent product releases including lower-end devices. This information may influence investor sentiment regarding AAPL's market performance.
Read More
Goldman Sachs Reiterates $250 Price Target for Nvidia Stock After GTC
Goldman Sachs has reiterated its $250 price target for Nvidia (NVDA) following the GTC event. At the time of writing on March 21, 2026, Nvidia was trading at $172.70. The firm emphasizes confidence in Nvidia's AI growth potential and maintains a buy rating. Key financial forecasts include revenues of $215 billion for 2026, $393.6 billion for 2027, $521.5 billion for 2028, and $634.8 billion for 2029. Nvidia's projected earnings per share (EPS) are 4.52 for 2026, rising to 15.41 by 2029.
Read More
UBS Upgrades Price Target for EchoStar (SATS) Amid Positive Market Outlook
UBS has raised its price target on EchoStar Corporation (SATS), signaling a positive outlook for the company's stock. This upgrade comes as EchoStar continues to strengthen its position in the satellite communications sector, aiming to capitalize on the growing demand for broadband services. Analysts believe this could influence investor sentiment, potentially leading to an increase in share prices as the market reacts to improved expectations. Keeping an eye on the performance of SATS may be crucial for investors amidst ongoing developments in the telecommunications industry.
Read More
UBS Increases Price Target on Iovance Biotherapeutics Amid Growth Potential
UBS has raised its price target on Iovance Biotherapeutics (NASDAQ: IOVA), signaling confidence in the company's future growth amid ongoing developments in its cell therapy treatments. The adjustment reflects a positive outlook on Iovance's clinical trials and market position in the biotech sector. The new price target could influence investor sentiment and trading activity in biotech stocks as analysts adjust their forecasts. Iovance's innovation in cancer therapeutics continues to attract significant attention from investors and stakeholders.
Read More